事丰SHIFENG品牌怎么样 申请店铺

我要投票 事丰SHIFENG在医疗器械行业中的票数:664 更新时间:2026-01-23
事丰SHIFENG是哪个国家的品牌?「事丰SHIFENG」是 成都市新津事丰医疗器械有限公司 旗下著名品牌。该品牌发源于四川省成都市,由创始人石 * 社在1998年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力事丰SHIFENG品牌出海!将品牌入驻外推网,定制事丰SHIFENG品牌推广信息,可以显著提高事丰SHIFENG产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

事丰SHIFENG怎么样

成都市新津事丰医疗器械有限公司是中国西部地区生产一次性无菌医疗器械系列产品的企业。生产基地位于新津,公司始建于1991年,于1998年成功改制,在中国西部同行业中,通过了中国医疗器械质量认证中心(CMD)ISO9001质量体系认证和欧盟CE认证。2007年公司成为中国医疗器械行业协会副理事长单位,中国注输器具标准化技术委员会委员单位。

成都市新津事丰医疗器械有限公司拥有强大的生产制造能力,拥有通过CNAS认可的检测中心。目前公司总资产2.5亿元人民币,员工约1000人;占地21万平方米,建筑面积8万平方米。产品有50多个品种,24300多种规格。 公司从2006年开始,积极参加国外展会,陆续开发国际市场,目前公司产品现已远销亚洲、欧洲、非洲、南美洲等三十来个国家和地区。

成都市新津事丰医疗器械有限公司多年来一直专注并投入大量的资金对于Ⅰ、Ⅱ、Ⅲ类医疗器械的设计研发,从1998年改制至今,已自行设计研发医疗器械30多种,拥有自主知识产权的发明专利等专利200多项,公司从建立现代企业制度优化法人治理结构入手,导入ISO9001质量保证体系,特别是近年来引入专业的3P管理模式和ERP、CRM、OA、HR等信息化平台,使质量控制、生产效率和销售服务得到了共同提升。,与英国StarSyringe公司成功技术合作K1型自毁式注射器;自行研制开发了胰岛素注射器、精密袋式输液器、一次性使用留置针,使产品结构逐步从单一品种向适应市场需求的、科技含量高的方向发展。


Chengdu Xinjin Shifeng Medical Equipment Co., Ltd. is an enterprise that produces disposable sterile medical equipment series products in Western China. The production base is located in Xinjin. The company was founded in 1991 and successfully restructured in 1998. In the same industry in Western China, it has passed ISO9001 quality system certification of China Medical Device Quality Certification Center (CMD) and CE certification of European Union. In 2007, the company became vice chairman unit of China Medical Device Industry Association and member unit of China injection and Transportation Equipment Standardization Technical Committee. Chengdu Xinjin Shifeng Medical Equipment Co., Ltd. has a strong manufacturing capacity and a CNAs approved testing center. At present, the company has a total assets of 250 million yuan, about 1000 employees, an area of 210000 square meters and a building area of 80000 square meters. There are more than 50 varieties and more than 24300 specifications. Since 2006, the company has actively participated in foreign exhibitions and developed international markets. At present, its products have been exported to more than 30 countries and regions in Asia, Europe, Africa and South America. Chengdu Xinjin Shifeng medical device Co., Ltd. has been focusing on and investing a lot of money in the design and development of class I, II and III medical devices for many years. Since the reform in 1998, it has designed and developed more than 30 kinds of medical devices by itself, and has more than 200 patents such as invention patents with independent intellectual property rights. Starting from the establishment of modern enterprise system and optimization of corporate governance structure, the company has introduced ISO9 001 quality assurance system, especially the introduction of professional 3P management mode and ERP, CRM, OA, HR and other information platforms in recent years, has jointly improved quality control, production efficiency and sales service. With the successful technical cooperation with starsyringe company of the United Kingdom, K1 self destructed syringe has been developed; insulin syringe, precision bag infusion set and disposable retention needle have been developed by ourselves, making the product structure gradually develop from a single product to a high-tech one that meets the market demand.

本文链接: https://brand.waitui.com/d5e55f711.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

2小时前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

2小时前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

2小时前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

2小时前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

2小时前

本页详细列出关于事丰SHIFENG的品牌信息,含品牌所属公司介绍,事丰SHIFENG所处行业的品牌地位及优势。
咨询